Blood-Based Approach to PD-L1 Detection Shows Concordance with Immunohistochemistry
The investigational methodology incorporates CK19 expression to identify PD-L1 derived from activated immune cells and tumor cells.
Read More
Search Results for: lung cancer
Combined Methods Show Promise for Early Detection of Lung Cancer
Gilupi has shared results of a study examining the detection of circulating tumor cells in the blood of pulmonary disease patients.
Read More
Natera Chosen for Circulating Tumor DNA Study in Breast Cancer
Natera is collaborating with Imperial College London and the University of Leicester to evaluate use of the company’s Signatera research-use-only personalized ctDNA technology for detecting disease recurrence among women breast cancer patients.
Read More
FDA Approves First Multiplexed Companion Diagnostic for Solid Tumors
The Centers for Medicare and Medicaid Services at the same time proposed coverage of the F1CDx test from Foundation Medicine, which detects genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
Read More
Study: Proteomic Test Can Guide Treatment for Lung Cancer Patients
A comprehensive literature review finds that the Biodesix VeriStrat test can aid in more precise treatment prognosis to inform treatment choice for patients with non-small cell lung cancer.
Read More